Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

Size: px
Start display at page:

Download "Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011"

Transcription

1 Netcare Limited AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2011

2 Agenda RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

3 Group overview

4 Group overview South Africa (SA) Solid performance across all divisions and excellent working capital improvements Continued contribution to job creation, training and skills development Continued investment in infrastructure development Guaranteed minimum wage increases across the board United Kingdom (UK) Tough trading conditions continue Green shoots in self-pay but no recovery in PMI Excellent working capital and cash flow Debt covenants met and refinancing of PropCo receiving attention 4

5 Group financial overview Good SA results but weaker performance in the UK 3.3% revenue 0.2% operating profit 12.3% pre-tax profit Cash conversion of 113.4% (2010: 101.4%) Net debt 10.9% in SA 4.8% in UK R1 492m total reduction 21.2% basic HEPS 14.0% distributions per share (DPS) 5

6 Geographic contribution Revenue (%) EBITDA (%)* Net interest paid (%) HEPS (%) UK SA 6

7 South Africa

8 Business overview Strong performance across EBITDA margin expansion to 19.4% all divisions (2010: 17.7%) Net debt to equity ratio of 52.7% (2010: 68.0%) Cash conversion of 116.0% (2010: 109.6%) 126-bed Waterfall City in Midrand 425-bed Queen Mamohato Memorial Hospital Lesotho PPP 4.9% cumulative bed capacity: 447 beds ( ) - Lesotho PPP 447 beds Hospital debtors days 26.8 days (2010: days) 8

9 South Africa: a comprehensive network of healthcare services Sites Hospitals PPP hospitals¹ 4 5 Primary health facilities Dialysis units Emergency bases Pharmacies Registered beds Employees¹ Patient visits Includes SA and Lesotho 9

10 South Africa Rm 30 Sep Sep 2011 % Revenue EBITDA* Operating profit* EBITDA margin (%) Operating profit margin (%) Cash conversion ratio (%) Revenue growth tempered by reduction in Primary Care revenue Strong operating leverage with focus on quality of earnings and operational efficiencies Record cash conversion * Before capital charges 10

11 Netcare s community reach Employment Inpatient Outpatient Surgical Births growth through economic downturn hospital admissions and primary healthcare visits operations 2 514* > >3.8 million > > Education Closing the wage gap Community sponsorships Partnering in extending free access to healthcare >8 300 people in 2011 (> since inception) 15.4% in 2011: highest minimum wages in hospital sector >R >8 700 patients in 2011 (> since inception) * September 2007 to October 2011, includes Lesotho 11

12 Burden of diseases and new technology will continue driving future healthcare expenditure Increase in medical scheme spend on hospitalisation (pbpm), * 51.2% Real price inflation contributed 4.9% of total increase in private hospital expenditure 4.9% Increased utilisation contributed 44.0% of total increase in private hospital expenditure 44.0% Price regulation will not, in itself, address the challenge of increased health needs CPIX Real price Utilisation * Applying Netcare price increases as a proxy for the private hospital sector Source: Netcare submission: Discussion document: The determination of health prices in the private sector 12

13 Quality leadership: a Group-wide focus and strategy to drive quality care National Department of Health core standards: all 55 hospitals benchmarked by February 2012 in preparation for NHI First accredited Level 1 Trauma Centres in SA (Netcare Milpark and Netcare Union hospitals) Benchmarking against USA hospitals Overall hospital rating: Overall, how satisfied were you with the service you received at our hospital? Netcare¹ 7% 34% 59% US² 8% 24% 68% Never or sometimes Usually Always 1. Netcare data over the period (54 hospitals): May August US data over the period (over hospitals): January December

14 Learning from best practice internationally and driving clinical quality improvement Improvement outcomes achieved in FY2011 Better than expected On target Less than expected Prevention of Healthcare Associated Infections Ventilator Associated Pneumonia (VAP) Surgical Site Infection (SSI) Central Line Associated Blood Stream Infection (CLABSI) Catheter Related Blood Stream Infections (CRBSI) Antibiotic stewardship Optimising care in Acute Myocardial Infarction (AMI) Prevention of Deep Vein Thrombosis (DVT)* Benchmarking outcomes in neonatal intensive care to the Vermont Oxford Network Elevating cardiopulmonary resuscitation response Netcare 911: monitoring helicopter emergency service outcomes* Netcare 911: monitoring fixed wing emergency service outcomes* National Renal Care: international benchmarks of dialysis outcomes* * Unique to Netcare 14

15 SA Hospitals and Emergency services Rm 30 Sep Sep 2011 % Revenue EBITDA* Operating profit* EBITDA margin (%) Operating profit margin (%) % revenue per patient day 14.4% in 911 road activity 2.2% patient days 178 additional beds 1.4 million pharmacy scripts Strong operating leverage resulting in widening of EBITDA margin * Before capital charges 15

16 Examples of major SA capex projects 76% 100% 64% 52% 50% 24% 36% 48% 50% Netcare Montana Netcare St Anne's Netcare The Bay Netcare Mulbarton Netcare Kingsway 54 beds 63 beds 64 beds 57 beds 35 beds and thereafter 16

17 Netcare Waterfall City Hospital opened in July 2011 in Midrand 17

18 Primary Care: stabilised operations EBITDA (Rm) 65 EBITDA margin improvement from 2.1% to 5.1% pharmacies 568 doctors and dentists 88 medical centres (24) managed care lives (2010: ) 1.7 million pharmacy scripts 3.2 million primary healthcare visits

19 425-bed Queen Mamohato Memorial Hospital opened in October 2011 in Lesotho 19

20 United Kingdom

21 Business overview Trading conditions remain difficult Stephen Collier appointed CEO and management team being strengthened EBITDA margins impacted by funder mix and non-core business mix 4.2% inpatient and day caseload Outstanding working capital Record cash hbalance of 130.6m Net debt reduced by 89.8m and bank covenants met 21

22 GHG is an amalgamation of various businesses BMI facilities Owned hospitals Leased and managed hospitals Transform (cosmetic) 2 2 Care Fertility 4 4 Netcare UK (NHS treatment t t centres) 3 1 Registered beds Employees Patient episodes

23 UK income statement m 30 Sep Sep 2011 % Revenue EBITDA before items below (14.5) Profit on disposal of property Gain on bargain purchase IPO costs (2.5) - Reported EBITDA (9.5) EBITDA margin (%) Reported EBITDA margin (%) Decline in PMI caseload Strong NHS growth Abbey and Transform acquisitions Affected by: business mix and lower private volumes cessation of Netcare UK contracts with NHS VAT increase joint venture provisions stamp duty refund Improvement of EBITDA margin H2 vs H1 23

24 EBITDA margins impacted by lower margin OpCo acquisitions Owned hospitals Leased and managed Transform Care Netcare hospitals (cosmetic) Fertility UK PMI Self-pay NHS EBITDA 24.5% 10.8% 34% 3.4% 31.1% 1% 32.4% Heritage portfolio plus Magnolia* Acquired for nominal Acquired for no Largest independent acquisition cash outlay cash outlay fertility service provider in UK Leeds Commuter Walk-in Centre contract ends Nov 2011 * Hospitals purchased from Nuffield 24

25 Caseload and funder mix continues to be impacted by economy Caseload 23.0% in NHS cases NHS is slowing outsourcing as financial constraints bite Nicholson Challenge remains Self-pay recovering off a low base driven by NHS waiting lists s Unemployment led contraction in insured lives Trend likely to continue in Insured Self-pay NHS 25

26 Financial review

27 Factors influencing results Exchange rate Average rate of R11.09 (2010: R11.63); closing rate of R12.54 (2010: R10.93) Interest rate swaps Liability increased to 422.7m (2010: 374.2m) Ineffective portion was a credit of 2.8m (2010: charge of 8.7m) UK property sales Two properties sold: Duchy Hospital (Harrogate), Harbour Hospital (Poole) Capital profit of 15.0m realised UK tax rate Reductions in UK statutory tax rate of 2% (2010: 1%) Benefit of non-cash deferred tax release of 27.5m (2010: 13.7m) 27

28 Exchange rate spike at year end Minimal impact on earnings: Revenue 2.0% EBITDA 1.6% 11 Significant impact on financial position NAV R546m 10 Sep 09 Jan 10 May 10 Sep 10 Jan 11 May 11 Sep 11 28

29 Summarised Group income statement Rm 30 Sep Sep 2011 % Revenue EBITDA Depreciation and amortisation (1 157) (1 213) Operating profit (0.2) Net financial i expenses (1 978) (1 755) 11.3 Attributable earnings of associates Profit before taxation Taxation (294) (114) 61.2 Profit for the period Growth in both geographies in constant currencies Improvement in SA impacted by UK performance Lower debt base and swap ineffectiveness credit of R42m (2010: R103m charge) Benefit of UK tax rate reduction of R301m (2010: R157m) 29

30 Headline earnings and distributions per share HEPS (cents) DPS (cents) H1 H2 H1 H2 30

31 Summarised statement of financial position Rm 30 Sep Sep 2011 Forex effect Movement Assets PPE, goodwill and intangible assets (45) Other non-current assets Current assets Deferred tax asset of R2 165m Investments in associates of R289m Total assets Equity and liabilities Total shareholders equity Reduction in both SA and UK debt Borrowings (1 070) Other liabilities Deferred tax liability of R5 178m Swap liability of R5 319m Total equity and liabilities

32 Movement in Group property, plant & equipment and intangible assets Rm (1 213) (240) 2010 Additions Depreciation Disposals Exchange rate 2011 and amortisation and other impact 32

33 Group debt Geographic split of net debt at 30 Sep 2011 Net debt at 30 September Sep 30 Sep % 87% UK debt ( m) (4.8) UK debt (Rm) SA debt (Rm) (10.9) Net debt (Rm) % Cost of debt (%) UK debt SA UK SA debt Group debt

34 SA debt position at lowest level in five years Improved GCR rating in Jan 2011: A Long-term (Feb 2009 A-) A1 Short-term (Feb 2009 A1-) Convertible bond repaid in September 2011 replaced by R1bn DMTN debt raise in August Gross debt (Rm) Interest cover (times) 1. DMTN: Domestic medium-term notes 34

35 UK debt: ring-fenced and non-recourse to SA operations Secured banking facilities ( m) The 4 categories of UK debt are ring-fenced from each other 47.5 There is no cross-default across debt categories All UK debt is non-recourse to SA operations 20.2 PropCo 1 debt maturity (Oct 2013) OpCo Transform PropCo 1 PropCo 2 Various options under consideration 35

36 Working capital 30 Sep Sep 2011 Movement SA (Rm) Inventories (18) Trade and other receivables Trade and other payables (1 764) (2 250) 486 Taxation payable (250) (164) (86) Net working capital 92 (387) 479 UK ( m) Receivables at record lows in both geographies Result of continued focus on cash collection and alignment of payables and receivables profiles Net working capital

37 Cash conversion SA (Rm) UK ( m) 109.6% 116.0% 93.9% 9% 103.4% EBITDA Cash flow from operations 37

38 Guidance

39 Guidance 2012 South Africa (SA) Estimated revenue growth upper single digit Continued focus on efficiencies and cost reductions Capex: ±R1bn United Kingdom (UK) Tough trading conditions expected to continue Further decline in PMI forecast Capex: < 50m 39

40 Disclaimer Netcare has acted in good faith and has made every reasonable effort to ensure the accuracy and completeness of the information contained in this presentation, including all information that may be defined d as 'forward-looking statements'. t t Forward-looking statements may be identified by words such as 'believe', 'anticipate', 'expect', 'plan', 'estimate', 'intend', 'project', 'target', 'predict' and 'hope'. By their nature, forward-looking statements are inherently predictive, speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future, involve known and unknown risks, uncertainties and other facts or factors which may cause the actual results, performance or achievements of the Group, or its industry to be materially different from any results, performance or achievement expressed or implied by such forward-looking statements. Forward-looking statements are not guarantees of future performance and are based on assumptions regarding the Group s present and future business strategies and the environments in which it operates now and in the future. No assurance can be given that forward-looking statements will prove to be correct and undue reliance should not be placed on such statements. Netcare does not undertake to update any forward-looking statements contained in this document and does not assume responsibility for any loss or damage whatsoever and howsoever arising i as a result of the reliance by any party thereon. 40

41 Thank you

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012

Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 Netcare Limited UNAUDITED GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2012 1 RICHARD FRIEDLAND GROUP CEO Group overview South Africa United Kingdom KEITH GIBSON GROUP CFO Financial review Guidance

More information

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED UNAUDITED INTERIM GROUP RESULTS FOR THE SIX MONTHS ENDED 31 MARCH 2016 Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive network

More information

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION

NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 CARE DIGNITY TRUTH PARTICIPATION PASSION NETCARE LIMITED AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2016 PRESENTATION OUTLINE Group Overview South Africa United Kingdom Financial Review Guidance GROUP OVERVIEW 4 Group A comprehensive

More information

Netcare Limited Interim results presentation For the six months ended 31 March 2008

Netcare Limited Interim results presentation For the six months ended 31 March 2008 1 Netcare Limited Interim results presentation For the six months ended 31 March 2008 Note regarding forward looking statements The Company advises investors that any forward looking statements or projections

More information

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION

Living our values. Netcare Limited Audited Group Results. for the year ended 30 September 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION CARE DIGNITY PARTICIPATION TRUTH PASSION Netcare Limited Audited Group Results for the year ended tember 2008 CARE DIGNITY PARTICIPATION TRUTH PASSION Note regarding forward looking statements The Company

More information

care helping for the health of humankind Netcare Limited 2014

care helping for the health of humankind Netcare Limited 2014 helping care for the health of humankind Netcare Limited 2014 AUDITED GROUP RESULTS for the year ended 30 September 2014 Contents Financial highlights 1 Commentary 2 Declaration of final dividend 9 Group

More information

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS

NETCARE LIMITED SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS for the year ended 30 September 2017 01 contents02 Commentary 10 Declaration of final dividend 12 Group statement of profit or loss 13 Group statement of other comprehensive

More information

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015

Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 www.lifehealthcare.co.za Group Results and Cash Dividend Declaration Unaudited Group results for the six month period ended 31 March 2015 Operational review André Meyer CEO 2 Highlights Group SA: 3.5%

More information

H1 16 interim results. 22 September 2015

H1 16 interim results. 22 September 2015 H1 16 interim results 22 September 2015 Important notice 2 This presentation may include certain forward-looking statements, beliefs or opinions, including statements with respect to the Company s business,

More information

DATATEC GROUP UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016

DATATEC GROUP UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016 Technology Distribution Integration & Managed Services Consulting & Research UNAUDITED INTERIM RESULTS FOR THE 6 MONTHS ENDED 31 AUGUST 2016 AGENDA Results summary, market conditions & operational strategy

More information

DATATEC GROUP AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018

DATATEC GROUP AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018 Technology Distribution Integration & Managed Services Consulting & Research AUDITED PROVISIONAL RESULTS FOR THE YEAR ENDED 28 FEBRUARY 2018 AGENDA Results summary, overview & strategic update Jens Montanana,

More information

MTN Group Limited Results presentation for the six months ended 30 June 2017

MTN Group Limited Results presentation for the six months ended 30 June 2017 MTN Group Limited Results presentation for the six months ended 30 June 2017 Disclaimer The information contained in this document has not been verified independently. No representation or warranty express

More information

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier

Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier Acquisition of Capio UK 7 September 2007 Managing Director, Pat Grier AGENDA 2 Executive Summary Why the UK Hospital Sector? Capio UK Business Overview Transaction Overview Financials Compelling Proposition

More information

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017

ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 ANNUAL RESULTS FOR THE YEAR ENDED 31 AUGUST 2017 PRESENTATION OUTLINE Review of the year Financial results Trading performance Outlook Questions 2 REVIEW OF THE YEAR DAVID KNEALE REVIEW OF THE YEAR Strong

More information

INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015

INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015 INTERIM RESULTS FOR THE SIX MONTHS ENDED 28 FEBRUARY 2015 PRESENTATION OUTLINE Review of the period Financial results Trading performance Outlook Questions CLICKS GROUP INTERIM RESULTS 2015 2 REVIEW OF

More information

Interim Results. Six months ended 31 August 2016

Interim Results. Six months ended 31 August 2016 Interim Results Six months ended 31 August 2016 Stefanutti Stocks City A multi-disciplinary construction group (Vision) (Mission) 2 www.stefanuttistocks.com y 2 Agenda Six month overview Operational Overview

More information

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions

PRESENTATION OUTLINE. Review of the period Financial results Trading performance Outlook Questions PRESENTATION OUTLINE Review of the period Financial results Trading performance Outlook Questions 2 REVIEW OF THE PERIOD DAVID KNEALE REVIEW OF THE PERIOD Strong health & beauty sales performance Increased

More information

2018 Half Year Results Presentation. 18 September 2018

2018 Half Year Results Presentation. 18 September 2018 2018 Half Year Results Presentation 18 September 2018 Disclaimer These materials contain certain forward-looking statements relating to the business of Spire Healthcare Group plc (the Company ), including

More information

Capital allocation and enhanced risk management

Capital allocation and enhanced risk management Capital allocation and enhanced risk management MTN Group Limited Ralph Mupita Group CFO UBS conference 26 March 2018 Agenda 1 2 3 Recap on 2017 results Capital allocation Enhanced risk management 2 Recap

More information

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015

Genesis HealthCare. A Leading National Provider of Post-Acute Services. August 2015 Genesis HealthCare A Leading National Provider of Post-Acute Services August 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare

More information

Forward Looking Statements

Forward Looking Statements MLP Care 1Q2018 Presentation 8 May 2018 Forward Looking Statements This presentation may contain certain forward-looking statements concerning MLP Care s future performance and should be considered as

More information

2010 Annual Results. November 2010

2010 Annual Results. November 2010 2010 Annual Results November 2010 1 Agenda Highlights Group results Operational review Strategic Update 2 Highlights Operating profit up 126% Trading margin improved from 5.8% to 8.3% Sale/closure of under-performers

More information

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007

Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 Briefing 25 February 2008 Financial Results Half Year ended 31 December 2007 AGENDA Ramsay Financial Performance Pre Capio UK ( Ramsay UK ) Ramsay Financial Performance Including Ramsay UK Operational

More information

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director

5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director 5th Annual Citi Australia and New Zealand Investment Conference London 10 March 2008 Pat Grier, Managing Director AGENDA About Ramsay Health Care The Reason for Ramsay s Success December 07 Half Year Results

More information

FY16 YEAR END RESULTS 5 APRIL 2016

FY16 YEAR END RESULTS 5 APRIL 2016 FY16 YEAR END RESULTS 5 APRIL 2016 DEFINITIONS AND IMPORTANT NOTICE The following definitions apply throughout Trading EBITDA (earnings before interest, tax, depreciation and amortisation): excludes exceptional

More information

Investing for the future: Spire

Investing for the future: Spire Investing for the future: Spire Healthcare Aslam Dalvi - Associate Portfolio Manager The UK public healthcare system has come under increasing pressure in recent times. An ageing population coupled with

More information

Annual results presentation

Annual results presentation Annual results presentation Disclaimer The following presentation is being made only to, and is only directed at, persons to whom such presentations may lawfully be communicated ( relevant persons ) ).

More information

FY2014 Full year results

FY2014 Full year results FY2014 Full year results Peter Watson CEO I Managing Director Ian Poole Chief Financial Officer 28 August 2014 FY2014 year in review Resources capital expenditure conditions subdued Strong underlying result

More information

Highlights of the Group s performance include:

Highlights of the Group s performance include: MEDIA RELEASE 21 November 2017 LIFE HEALTHCARE GROUP POSTS SOLID RESULTS POST ALLIANCE MEDICAL ACQUISITION Johannesburg, 21 November 2017: Life Healthcare Group Holdings Limited (JSE: LHC), one of South

More information

INTERIM FINANCIAL RESULTS FOR THE PERIOD ENDED 30 SEPTEMBER NOVEMBER 2018

INTERIM FINANCIAL RESULTS FOR THE PERIOD ENDED 30 SEPTEMBER NOVEMBER 2018 INTERIM FINANCIAL RESULTS FOR THE PERIOD ENDED 30 SEPTEMBER 2018 13 NOVEMBER 2018 Disclaimer The information contained in this presentation has not been subject to any independent audit or review and may

More information

PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015

PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015 PRESENTATION TO INVESTORS FOR THE YEAR ENDED 30 SEPTEMBER 2015 AGENDA GROUP OVERVIEW Alan Dickson, CEO FINANCIAL OVERVIEW Nick Thomson, CFO SEGMENTAL DISCUSSIONS ICT Mark Taylor Applied electronics Peter

More information

NETCARE LIMITED 2017

NETCARE LIMITED 2017 NETCARE LIMITED ANNUAL FINANCIAL STATEMENTS 2017 contents ANNUAL FINANCIAL STATEMENTS 02 Directors' responsibility and approval 02 Certificate by the Company Secretary 03 Directors' report 10 Audit Committee

More information

Polypipe Group plc Interim Results

Polypipe Group plc Interim Results Polypipe Group plc Interim Results 6 months to 30 June 2017 Disclaimer The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

EVRY ASA Q PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER

EVRY ASA Q PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER 1 EVRY ASA Q3 2018 PRESENTATION CEO BJÖRN IVROTH CFO HENRIK SCHIBLER Agenda Group highlights Business update Financial highlights Business area performance Concluding remarks Q&A 2 Group highlights Q3

More information

ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012

ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012 ANALYST PRESENTATION FOR THE YEAR ENDED 31 MARCH 2012 1 TFG ANALYST PRESENTATION MARCH 2012 AGENDA Overview of the economy and retail environment Review of the year Financial review Divisional review Financial

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services November 2015 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018

MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018 MLP Care Analyst Meeting Liv Hospital Ulus, March 7 th 2018 MLP Overview Dr. Muharrem Usta Chairman and CEO 2 Summary Results above our expectations Growth across all segments Double digit growth in Net

More information

INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018

INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018 INTERIM RESULTS PRESENTATION SIX MONTHS TO 30 JUNE 2018 DISCLAIMER The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016 AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2016 AGENDA 2 1 Opening remarks / market update 2 Financial results 3 Operational review 4 Strategy update 5 Outlook 1 2 3 4 5 OPENING REMARKS / MARKET UPDATE

More information

12 month overview. Operational Overview. Financial Results. Conclusion

12 month overview. Operational Overview. Financial Results. Conclusion Annual Results 12 months ended 29 ruary 2016 Agenda 12 month overview Operational Overview Financial Results Conclusion 2 1 12 month overview Reasonable financial performance in current market All Business

More information

WEB CAST PRESENTATION

WEB CAST PRESENTATION WEB CAST PRESENTATION interim report Fredrik Rågmark, CEO & Joe Ryan, CFO Stockholm 27 July, DISCLAIMER REGARDING FORWARD-LOOKING STATEMENTS This presentation may contain certain forward-looking statements

More information

A Leading National Provider of Post-Acute Services

A Leading National Provider of Post-Acute Services A Leading National Provider of Post-Acute Services February 2016 Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of the Skilled Healthcare transaction, future

More information

SUMMARISED AUDITED GROUP RESULTS

SUMMARISED AUDITED GROUP RESULTS SUMMARISED AUDITED GROUP RESULTS OF MEDICLINIC INTERNATIONAL LIMITED AND ITS SUBSIDIARIES FOR THE YEAR ENDED 31 MARCH AND DECLARATION OF CASH DIVIDEND Incorporated in the Republic of South Africa Registration

More information

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018,

Group UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, UNAUDITED GROUP RESULTS FOR THE PERIOD ENDED 31 MARCH 2018, SCRIP DISTRIBUTION WITH CASH DIVIDEND ALTERNATIVE, FURTHER CAUTIONARY AND TRADING STATEMENT Group LIFE HEALTHCARE UNAUDITED GROUP RESULTS 2018

More information

Period overview Operational Overview Financial Results Conclusion

Period overview Operational Overview Financial Results Conclusion Interim Results Six months ended 31 ust 2015 Bridging y expectations Agenda Period overview Operational Overview Financial Results Conclusion Bridging y expectations 2 1 Six month overview Satisfactory

More information

Management s Discussion & Analysis

Management s Discussion & Analysis Management s Discussion & Analysis For the three month interim period ended March 31, 2014 Medworxx Solutions Inc. 700-121 Richmond St W. Toronto, ON M5H 2K1 This Management s Discussion and Analysis (

More information

Vodacom Group (Proprietary) Limited

Vodacom Group (Proprietary) Limited Driving the future of communication Vodacom Group (Proprietary) Limited For the year ended March 31, 2005 June 6, 2005 Content Alan Knott-Craig Chief Executive Officer Operational highlights Leon Crouse

More information

PRESENTATION TO FUND MANAGERS & FINANCIAL ANALYSTS. 25 November 2013

PRESENTATION TO FUND MANAGERS & FINANCIAL ANALYSTS. 25 November 2013 1 PRESENTATION TO FUND MANAGERS & FINANCIAL ANALYSTS Business update 25 November 2013 2 Agenda 01 02 03 04 02 03 04 SECTION 1 SECTION 2 SECTION 3 SECTION 4 Focusing on growth Group Five business model

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services November 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

Financial Year Results Presentation

Financial Year Results Presentation 2016 Financial Year Results Presentation Disclaimer Important information: forward-looking statements These materials contain certain forward-looking statements relating to the business of Spire Healthcare

More information

2017 Full Year Results. Tuesday 21 November 2017

2017 Full Year Results. Tuesday 21 November 2017 2017 Full Year Results Tuesday 21 November 2017 Disclaimer Certain information included in the following presentation is forward looking and involves risks, assumptions and uncertainties that could cause

More information

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017

TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 TRELLIDOR HOLDINGS LIMITED UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2017 GROUP HIGHLIGHTS 5% Revenue 5% PAT 5% HEPS 35.2c 5% Interim dividend declared 11.0 cents per share Slide 2

More information

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018

1H18 results. Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 1H18 results Dr. Ian Kadish (MD & CEO) Anne Lockwood (CFO) 19 January 2018 Today s presenters Dr. Ian Kadish Managing Director and Chief Executive Officer Joined Integral Diagnostics in May 2017 Has held

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services March 2018 2018 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits

More information

FY 2015 Results Presentation. 19 January 2016

FY 2015 Results Presentation. 19 January 2016 FY 2015 Results Presentation 19 January 2016 Disclaimer THIS PRESENTATION IS NOT AN OFFER OR SOLICITATION OF AN OFFER TO BUY OR SELL SECURITIES IN THE UNITED STATES OF AMERICA OR IN ANY OTHER JURISDICTION.

More information

Looking to the medium term

Looking to the medium term Looking to the medium term Issued: 4 September 2013 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

BANNER HEALTH Investor Conference Call

BANNER HEALTH Investor Conference Call BANNER HEALTH Investor Conference Call Year Ended December 31, 2012 and Quarter Ended March 31, 2013 May 30, 2013 Dennis Dahlen, Senior Vice President / Chief Financial Officer Banner Health Snapshot 23

More information

THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September 12, 2013 UI HOSPITAL DASHBOARD

THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September 12, 2013 UI HOSPITAL DASHBOARD THE UNIVERSITY OF ILLINOIS HOSPITAL & HEALTH SCIENCES SYSTEM: BOARD OF TRUSTEES MEETING September, 2013 UI HOSPITAL DASHBOARD HOSPITAL FINANCIAL PERFORMANCE FOR THE YEAR ENDING 6/30/13 METRIC FY 2013 Unaudited

More information

YEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director

YEAR END RESULTS 31 MARCH Russell Down, Chief Executive Chris Morgan, Group Finance Director YEAR END RESULTS 31 MARCH 2018 Russell Down, Chief Executive Chris Morgan, Group Finance Director Customer service strategy improving performance Revenue (excluding disposals) 371.6m 6.4% FY17: 349.1m

More information

PMB Review: What s next? Evelyn Thsehla Clinical Researcher

PMB Review: What s next? Evelyn Thsehla Clinical Researcher PMB Review: What s next? Evelyn Thsehla Clinical Researcher Contents Background PMB Development Identified Gaps PMB review phases Proposed Intervention Work-plans Conclusion Background The Medical Schemes

More information

Interim FY 2015 results 6 months ended 31 December February 2015

Interim FY 2015 results 6 months ended 31 December February 2015 Interim FY 2015 results 31 December 2014 18 February 2015 Highlights Solid trading result for 1H FY2015; change in accounting policy for acquisition of healthcare practices First half result highlights

More information

Vita Group (VTG)! Results Presentation!

Vita Group (VTG)! Results Presentation! Vita Group (VTG) Results Presentation First half FY14 Group highlights Sustained trend of strong profit, dividend growth Underlying EBITDA 1 +18%, underlying NPAT 2 +56%, dividend +66% Areas of strategic

More information

A leading provider of post acute services

A leading provider of post acute services A leading provider of post acute services May 2017 2017 by Genesis Healthcare, Inc. All Rights Reserved. Safe Harbor Statement Certain statements in this presentation regarding the expected benefits of

More information

Responsible investment in growth

Responsible investment in growth Responsible investment in growth Issued: 17 June 2014 Legal notice This presentation has been prepared to inform investors and prospective investors in the secondary markets about the Group and does not

More information

OVERVIEW Group highlights. The Maslow Hotel

OVERVIEW Group highlights. The Maslow Hotel OVERVIEW Group highlights The Maslow Hotel 2 Key indicators R5 407m R1 489m 334 cps 90 cps GROUP REVENUE GROUP EBITDA ADJ DILUTED HEPS DPS +4% (5%) (18%) (18%) 3 Kalahari Sands Operating environment Pressure

More information

Health PPPs. Can PPPs contribute to the UN Development Goals in the Health Sector "

Health PPPs. Can PPPs contribute to the UN Development Goals in the Health Sector Health PPPs Can PPPs contribute to the UN Development Goals in the Health Sector " XS-Axis Consulting GmbH Kaiser-Friedrich Promenade 93 61348 Bad Homburg t: +49 6081 9299977 m: +49 1523 4135686 1 Some

More information

Unaudited results for the 6 months ended 30 September H Investor Booklet November 2016

Unaudited results for the 6 months ended 30 September H Investor Booklet November 2016 H1 2017 Investor Booklet November 2016 Agenda Overview of Results Financial Review Outlook 2 Overview In the F2016 results presentation (14 July 2016) we said: Dawn board had approved a plan to stop losses

More information

SIX MONTHS ENDED 30 SEPTEMBER 2018

SIX MONTHS ENDED 30 SEPTEMBER 2018 PRESENTATION TUESDAY, 20 NOVEMBER 2018 SIX MONTHS ENDED 30 SEPTEMBER 2018 CONTENTS PRESENTED BY Neil Birch Chief Executive Officer Harry Todd Chief Financial Officer 2 EXECUTIVE OVERVIEW 3 RESULTS SUMMARY

More information

FY2019 Interim results presentation

FY2019 Interim results presentation EXPLORE OUR WORLD Established 1975 I Listed JSE limited 1987 ADCORP IS A WORKPLACE SOLUTIONS COMPANY Presented by Innocent Dutiro Chief Executive Officer Cheryl Jane CJ Kujenga Chief Financial Officer

More information

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015

AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015 AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2015 AGENDA 2 1 Opening remarks / market update Richard 2 Financial results David 3 Operational review Richard 4 Strategy update Richard 5 Outlook Richard

More information

Annual Results. 12 months ended 28 February Agenda

Annual Results. 12 months ended 28 February Agenda Annual Results 28 ruary 2015 Bridging y expectations Agenda 2015 2014 2 1 12 month overview Phase 1 of turnaround strategy successfully implemented Closed-out problem contracts Closed non-performing Power

More information

Fourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014

Fourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014 Fourth Quarter 2013 Financial Results Conference Call & Webcast April 1, 2014 Forward Looking Information & Disclosure Certain of the statements contained in this presentation are "forward-looking information

More information

enx Group Limited results presentation

enx Group Limited results presentation enx Group Limited results presentation for the year ended 31 August 2018 Disclaimer Certain statements in this presentation regarding enx s business operations may constitute forward looking statements.

More information

SUMMARY OF OPERATING RESULTS DECEMBER UWHC Finance Committee & Authority Board

SUMMARY OF OPERATING RESULTS DECEMBER UWHC Finance Committee & Authority Board SUMMARY OF OPERATING RESULTS DECEMBER 20 UWHC Finance Committee & Authority Board Adult Admissions,679,263,263 2,039 1,932 1,929 December 20 2014 YTD 2 Pediatrics Admissions 1,781 1,799 1,776 257 280 274

More information

OVERVIEW. Comparable HEPS up 4.5% Restaurant sales up 10.4% Comparable profit before tax up 5.0% Interim dividend per share up 6.

OVERVIEW. Comparable HEPS up 4.5% Restaurant sales up 10.4% Comparable profit before tax up 5.0% Interim dividend per share up 6. OVERVIEW Restaurant sales up 10.4% (from continuing operations) Comparable HEPS up 4.5% (from continuing operations) Comparable profit before tax up 5.0% (from continuing operations) Interim dividend per

More information

Fourth Quarter 2016 Performance Summary

Fourth Quarter 2016 Performance Summary Fourth Quarter 2016 Performance Summary Operational and Financial Highlights - 2016 Net profit rises by +2.5% to Euros 545.5 million Recurring sales (excluding Raw Materials and Others) rise by +4.5% (+4.6%

More information

news FOR IMMEDIATE RELEASE

news FOR IMMEDIATE RELEASE news FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Mark Kimbrough Ed Fishbough 615-344-2688 615-344-2810 HCA Reports First Quarter 2018 Results Nashville, Tenn., May 1, 2018 HCA Healthcare, Inc.

More information

2017 FULL YEAR RESULTS PRESENTATION

2017 FULL YEAR RESULTS PRESENTATION 2017 FULL YEAR RESULTS PRESENTATION MEDICLINIC RESULTS DISCLAIMER This presentation contains certain forward-looking statements relating to the financial condition, the regulatory environment in which

More information

For personal use only

For personal use only Ramsay Health Care Limited MACQUARIE SECURITIES AUSTRALIA CONFERENCE 2015 6 May 2015 Christopher Rex, Managing Director AGENDA 1. Ramsay Health Care Overview 2. Group Financial Highlights for the six months

More information

Corporate Performance Report 2015/16

Corporate Performance Report 2015/16 Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close

More information

Management s Discussion & Analysis

Management s Discussion & Analysis Management s Discussion & Analysis For the three and six month interim period ended June 30, Medworxx Solutions Inc. 700 121 Richmond St W. Toronto, ON M5H 2K1 This Management s Discussion and Analysis

More information

FY2015 Annual Results August Brett McKeon - CEO David Bailey - CFO

FY2015 Annual Results August Brett McKeon - CEO David Bailey - CFO FY2015 Annual Results August 27 2015 Brett McKeon - CEO David Bailey - CFO FY2015 Financial Results Highlights Delivery on FY15 Prospectus forecasts Pro forma NPAT $19.3 million up 8.4% against IPO forecast

More information

Dr. Anna Mokgokong Chairperson

Dr. Anna Mokgokong Chairperson Dr. Anna Mokgokong Chairperson To relentlessly innovate a new integrated model of sustainable healthcare that measurably improves access to quality care Empowering greater access to sustainable quality

More information

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer

2011 Interim Results. Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer 2011 Interim Results Keith Gordon, Managing Director & Chief Executive Officer Stephen Gobby, Chief Financial Officer Emeco 2011 Interim Results Overview Financials Strategy & Outlook Questions Appendices

More information

Press Release Stockholm 2 May 2017 MEDICOVER INTENDS TO LIST ON NASDAQ STOCKHOLM

Press Release Stockholm 2 May 2017 MEDICOVER INTENDS TO LIST ON NASDAQ STOCKHOLM Press Release Stockholm 2 May 2017 NOT FOR DISTRIBUTION, RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE

More information

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION

MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION MEDICLINIC INTERNATIONAL OVERVIEW PRESENTATION J.P. MORGAN HEALTHCARE CONFERENCE 10 JANUARY 2018 DANIE MEINTJES CEO MEDICLINIC INTERNATIONAL PLC MEDICLINIC RESULTS DISCLAIMER This presentation contains

More information

PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017

PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017 PRELIMINARY RESULTS PRESENTATION YEAR ENDED 31 DECEMBER 2017 DISCLAIMER The information contained in this presentation has not been independently verified and this presentation contains various forward-looking

More information

Presentation of consolidated results. For the 52 weeks ended 30 March 2013

Presentation of consolidated results. For the 52 weeks ended 30 March 2013 Presentation of consolidated results For the 52 weeks ended 30 March 2013 1 Agenda Strategic and operational update Financial review Looking forward Jürgen Schreiber CEO Mark Bower Deputy CEO & CFO Jürgen

More information

2018 half-year results presentation. 15 August 2018

2018 half-year results presentation. 15 August 2018 2018 half-year results presentation 15 August 2018 Forward-looking statements This presentation may include certain forward-looking statements, beliefs or opinions, including statements with respect to

More information

Fourth Quarter 2015 Performance Summary

Fourth Quarter 2015 Performance Summary Fourth Quarter 2015 Performance Summary Operational and Financial Highlights - 2015 Grifols revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million of the

More information

Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY15 Results

Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY15 Results Hero Acquisitions Limited (subsidiary of HSS Hire Group plc) 9M FY5 Results November 205 Agenda John Gill, CEO: Introduction Steve Trowbridge, CFO: 9M Results John Gill, CEO: Summary Q&A Introduction 0.7%

More information

Half year results 30 September 2017

Half year results 30 September 2017 Half year results 30 September November Russell Down, Chief Executive Chris Morgan, Group Finance Director Strong first half performance Revenue (excluding disposals) 183.2m 6.9% HY17: 171.4m EBITDA* 33.8m

More information

Investor & Analyst Presentation Ful YearResults 30 June2016 For personal use only 25th August 2016 Rebekah O Flaherty - CEO I Jonathan Kenny - CFO

Investor & Analyst Presentation Ful YearResults 30 June2016 For personal use only 25th August 2016 Rebekah O Flaherty - CEO I Jonathan Kenny - CFO Investor & Analyst Presentation Full YearResults 30 June2016 25th August 2016 Rebekah O Flaherty - CEO I Jonathan Kenny - CFO Agenda 1 Overview 2 Strategic Priorities 3 FY16 Financial Results 4 FY17 Outlook

More information

For personal use only 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R

For personal use only 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R 1H 2016 RESULTS 6 M O N T H S E N D E D 3 1 D E C E M B E R 2 0 1 5 17 FEBRUARY 2016 OVERVIEW 1H 2016 Underlying result in line with expectations Reported results strong supported by one-offs Strengthened

More information

FINAL RESULTS ANNOUNCEMENT. Year ended 28 February 2013

FINAL RESULTS ANNOUNCEMENT. Year ended 28 February 2013 FINAL RESULTS ANNOUNCEMENT Year ended 28 February 2013 WILDERNESS HOLDINGS AUDITED YEAR END RESULTS Agenda Welcome & board changes Parks Tafa, Chairman Review of the period to Feb 2013 Keith Vincent, Acting

More information

4Q18 Results Presentation. 27 August 2018

4Q18 Results Presentation. 27 August 2018 4Q18 Results Presentation 27 August 2018 1 Disclaimer This is a presentation of general information relating to the current activities of the Health Management International Ltd ( HMI ). It is given in

More information

LIFE STARTS HERE. FY18 Full Year Results Presentation. 27 August 2018

LIFE STARTS HERE. FY18 Full Year Results Presentation. 27 August 2018 LIFE STARTS HERE FY18 Full Year Results Presentation 27 August 2018 Disclaimer The presentation has been prepared by Monash IVF Group Limited (ACN 169 302 309) ( MVF ) (including its subsidiaries, affiliates

More information

Announcement of Q Results

Announcement of Q Results Announcement of Q3 2008 Results Conference Call October 15, 2008 2:00 p.m. CEST Dr. Axel Herberg, CEO Hans-Jürgen Wiecha, CFO 0 Disclaimer This presentation may contain certain forward-looking statements,

More information

RESULTS PRESENTATION FOR THE SIX MONTHS ENDED 30 JUNE 2018 PRESENTED BY ZANELE MATLALA (CEO) AND KAJAL BISSESSOR (FD)

RESULTS PRESENTATION FOR THE SIX MONTHS ENDED 30 JUNE 2018 PRESENTED BY ZANELE MATLALA (CEO) AND KAJAL BISSESSOR (FD) RESULTS PRESENTATION FOR THE SIX MONTHS ENDED 30 JUNE 2018 i PRESENTED BY ZANELE MATLALA (CEO) AND KAJAL BISSESSOR (FD) Merafe Resources Ltd Results presentation for the year ended 31 December 2017 LEGAL

More information

2015 Results Presentation. 14 March 2016

2015 Results Presentation. 14 March 2016 2015 Results Presentation 14 March 2016 Disclaimer and Basis of Preparation Disclaimer The information set out herein may be subject to updating, completion, revision and amendment and such information

More information